Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F5QB3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,735
Award facts
- Contract value 100% obligated
- $2,734.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,734.63 on November 20, 2025, for HEPLISAV-B 20 mcg/0.5 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HEPLISAV-B is a recombinant hepatitis B vaccine used for immunization of adults, reflecting the company's role as a critical supplier of pharmaceutical and medical products to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to meet diverse medical procurement requirements through open competition and flexible contract vehicles supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5QB3?
SPE2DR26F5QB3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F5QB3 worth?
The government has obligated $2,735 on SPE2DR26F5QB3.
Is contract SPE2DR26F5QB3 an order under another contract?
Yes. SPE2DR26F5QB3 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QB3 competed?
The extent of competition for SPE2DR26F5QB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award